People · Operator
Named in public records as an officer, director or promoter · active 2009–2026 · Biotechnology, Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| PROLOR Biotech, Inc. | — | Biotechnology | Series B | $26.4M | $968.4M | 2009 |
| CollPlant Biotechnologies Ltd | — | Biotech / Pharma | Series A | $17.8M | $9.9M | 2017 |
Abraham Havron at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Abraham Havron on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Steven D. Rubin | 1 | 9 |
| JANE H HSIAO | 1 | 5 |
| Hugh Evans | 1 | 4 |
| Adam Stern | 1 | 4 |
| Roger Pomerantz | 1 | 4 |
| Adam D. Stern | 1 | 3 |
| Phillip Frost | 1 | 3 |
| Alisa Lask | 1 | 3 |
| Adi Goldin | 1 | 2 |
| Shai Novik | 1 | 2 |
| Steve Schaeffer | 1 | 2 |
| Elan Penn | 1 | 2 |
| Joseph Zarzewsky | 1 | 2 |
| Jasmine Seror | 1 | 1 |
| Fuad Fares | 1 | 1 |
| Oren Fahimipoor | 1 | 1 |
| Bar Abelis | 1 | 1 |
| Eyal Fima | 1 | 1 |
| Philippe Bensimon | 1 | 1 |
| Yehiel Tal | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.